From Alphastreet - Earnings Decoded. Market Intelligence Delivered · AlphaStreet Newsdesk · · 50s
Haemonetics Stock Surges on CSL Plasma Deal Update
Haemonetics stock jumps 12.8% after announcing expanded supply deal with CSL Plasma.
In brief
Haemonetics stock jumps 12.8% after announcing expanded supply deal with CSL Plasma. Haemonetics Corporation's stock surged 12.8% to $114.69 following a significant update to its supply deal with CSL Plasma. Originally reported by Alphastreet - Earnings Decoded. Market Intelligence Delivered.
Haemonetics Stock Surges
Haemonetics Corporation surged 12.8% Thursday, closing at $114.69 after announcing a significant update to its supply deal with CSL Plasma.
Heavy Trading Volume
The stock’s rally came on heavy volume of 965,767 shares as investors cheered the expanded partnership with one of the world’s largest plasma collectors.
Strategic Partnership Impact
The catalyst driving the move centers on Haemonetics’ strengthened relationship with CSL Plasma, which provides predictable revenue streams and validation of its technology platform.
What to Watch Next
Investors should monitor whether Haemonetics can secure similar deals with other major plasma collectors to demonstrate the competitiveness of its platform.
What matters most
Haemonetics Corporation's stock surged 12.8% to $114.69 following a significant update to its supply deal with CSL Plasma.
